mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
0.093 |
0.8 |
mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0092 |
0.8 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
HC-067047 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |